AllianceBernstein’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $121M | Sell |
|
|||||
|
2025
Q2 | $139M | Sell |
|
|||||
|
2025
Q1 | $202M | Sell |
|
|||||
|
2024
Q4 | $199M | Sell |
|
|||||
|
2024
Q3 | $202M | Buy |
|
|||||
|
2024
Q2 | $156M | Sell |
|
|||||
|
2024
Q1 | $235M | Buy |
|
|||||
|
2023
Q4 | $205M | Sell |
|
|||||
|
2023
Q3 | $265M | Sell |
|
|||||
|
2023
Q2 | $302M | Buy |
|
|||||
|
2023
Q1 | $300M | Buy |
|
|||||
|
2022
Q4 | $216M | Buy |
|
|||||
|
2022
Q3 | $193M | Buy |
|
|||||
|
2022
Q2 | $205M | Sell |
|
|||||
|
2022
Q1 | $196M | Sell |
|
|||||
|
2021
Q4 | $173M | Sell |
|
|||||
|
2021
Q3 | $169M | Sell |
|
|||||
|
2021
Q2 | $215M | Sell |
|
|||||
|
2021
Q1 | $305M | Buy |
|
|||||
|
2020
Q4 | $256M | Sell |
|
|||||
|
2020
Q3 | $294M | Sell |
|
|||||
|
2020
Q2 | $330M | Buy |
|
|||||
|
2020
Q1 | $311M | Sell |
|
|||||
|
2019
Q4 | $365M | Buy |
|
|||||
|
2019
Q3 | $235M | Sell |
|
|||||
|
2019
Q2 | $218M | Buy |
|
|||||
|
2019
Q1 | $214M | Buy |
|
|||||
|
2018
Q4 | $197M | Sell |
|
|||||
|
2018
Q3 | $241M | Buy |
|
|||||
|
2018
Q2 | $212M | Sell |
|
|||||
|
2018
Q1 | $282M | Buy |
|
|||||
|
2017
Q4 | $175M | Sell |
|
|||||
|
2017
Q3 | $183M | Buy |
|
|||||
|
2017
Q2 | $150M | Sell |
|
|||||
|
2017
Q1 | $149M | Sell |
|
|||||
|
2016
Q4 | $185M | Sell |
|
|||||
|
2016
Q3 | $172M | Sell |
|
|||||
|
2016
Q2 | $237M | Buy |
|
|||||
|
2016
Q1 | $202M | Sell |
|
|||||
|
2015
Q4 | $217M | Sell |
|
|||||
|
2015
Q3 | $190M | Sell |
|
|||||
|
2015
Q2 | $226M | Sell |
|
|||||
|
2015
Q1 | $310M | Sell |
|
|||||
|
2014
Q4 | $289M | Sell |
|
|||||
|
2014
Q3 | $259M | Sell |
|
|||||
|
2014
Q2 | $247M | Sell |
|
|||||
|
2014
Q1 | $280M | Buy |
|
|||||
|
2013
Q4 | $245M | Sell |
|
|||||
|
2013
Q3 | $250M | Sell |
|
|||||
|
2013
Q2 | $264M | Buy |
|